Navigation Links
CPhI et CPhI Pharma Evolution ajoutent des noms réputés à leur panel d'experts du secteur
Date:7/16/2013

e et expert du paysage règlementaire indien et mondial, proposera des perspectives sur le futur paysage et les implications des changements potentiels pour les compagnies pharmaceutiques. Son expérience couvre plus de 45 années et, par l'intermédiaire de son cabinet de conseil (Vision), il travaille avec certaines des plus importantes sociétés au monde sur leur planification stratégique.

Emil Ciurczak fournit une gamme étendue de connaissances pharmaceutiques à travers les domaines de la spectroscopie, la PAT et la QbD, ayant lancé la consultance en spectroscopie NIR et rédigé plus de 200 documents techniques. Il a aussi précédemment été membre du comité sur la PAT de la FDA, et est actuellement président de Doramaxx Consulting. Le panel sera complété par William Botha, un mentor et formateur respecté en matière de fabrication. Il connaît parfaitement les règlementations de la FDA, y compris les bonnes pratiques de fabrication et de distribution, et a présenté un cours sur le traitement aseptique pour la PDA et un cours sur les Systèmes de qualité pour l'AAMI.

Pendant l'année 2013, les membres du panel participeront aux brefs rapports mensuels de CPhI - intitulés « CPhI Pharma insight series » - examinant des sujets d'actualité dans un total de huit thèmes généraux: l'administration des médicaments, la formulation et les ingrédients, la R&D, la fabrication, le conditionnement et la distribution, la conformité règlementaire, les services contractuels et la gestion de la chaîne logistique, ainsi que et l'AQ/CQ.

Le but ultime de
'/>"/>

SOURCE UBM Live
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cree, Intuitive Surgical, Alexion Pharmaceuticals, Roche and Onyx Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
2. Abuse-Deterrent Formulations of Purdues OxyContin and Endo Pharmaceuticals Opana ER Have Not Increased PCPs Comfort When Prescribing These Products for Chronic Pain
3. CPhI & CPhI Pharma Evolution Add Stellar Names to Expert Industry Panel
4. Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
5. GW Pharmaceuticals to Report Q3 2013 Results and Host Conference Call on 5 August, 2013
6. RXi Pharmaceuticals Announces Positive Data in Second Phase 1 Multi-Dose Study
7. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
8. Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
9. Trottas West Street Pharmacy Selected For "Best Of Westchester"
10. New Medication Management And Adherence App, MyMeds, Introduced For iPhone, Android, Web; Unites Consumers, Pharmacists, Caregivers, Physicians
11. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ANGELES , Sept. 30, 2014 ... biopharmaceutical research and development company specializing in oncology, ... 2b clinical trial evaluating aldoxorubicin compared to topotecan ... (SCLC) who have relapsed or were refractory to ... the widely-used chemotherapeutic agent, doxorubicin. CytRx has received ...
(Date:9/29/2014)... et SAN DIEGO ... Company, Ltd. (ci-après désignée Daiichi Sankyo) (TSE : 4568) ... aujourd,hui la conclusion d,un accord de fusion définitif ... la totalité des actions ordinaires en circulation d,Ambit ... par le biais d,une offre publique d,achat qui ...
(Date:9/29/2014)... Sept. 29, 2014  Bob Pack, who lost his ... on the California Medical Association to immediately cease airing ... the San Jose Mercury News called "shamelessly deceptive" and ... wants voters to believe about the measure is wrong." ... Prop 46 requirement that doctors check California,s ...
Breaking Medicine Technology:CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5
(Date:9/30/2014)... Computer Resources of America, Inc. ... in New York City, has been awarded a ... transform, manage, and support the IT environment of ... leading provider of innovative services that enable individuals ... The contract will cover the four NY-metro locations ...
(Date:9/30/2014)... All on Four dental implants ... have received dental implants to vigilant in the fight ... The post, which can be found at http://www.newalbanyimplants.com/dr-rons-blog/ ... don’t brush and floss diligently, they could lose their ... teeth: the bone will deteriorate and the implants will ...
(Date:9/30/2014)... Ontario, Canada (PRWEB) September 30, 2014 ... diagnostic imaging services based in San Juan, Puerto ... automate their workflows. , Nivia Souffront, site ... to their facility. “We are excited to bring ... to provide better patient care and physician satisfaction ...
(Date:9/30/2014)... Westminster, Maryland (PRWEB) September 30, 2014 3M ... of acrylic very high bond tapes. 3M 5906 , ... 3M 5909 are conformable VHBs which help create the ... acrylic foam tapes are used for bonding to difficult surfaces ... , 3M VHBs 5906, 5907, 5908, and 5905 are designed ...
(Date:9/30/2014)... Doctors often order breast ultrasounds as a ... Most breast ultrasounds are done at a specialized medical imaging ... Miami . The Center for Diagnostic Imaging is now ... Most patients find ultrasounds to be more comfortable as ... have to remain perfectly still. , “We realize ...
Breaking Medicine News(10 mins):Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Breast Ultrasounds Are a Comfortable and Convenient Option for Patients and Referring Doctors 2
... help medicine go down , , ... medicine go down" -- parents know in reality it just isn,t ... -- unique, frozen single-use packages that offer cooling, soothing relief to ... , Sucrets ICE is the newest member ...
... the definitive online resource for women who want to look fabulous ... Zuckerbrot, M.S., R.D., has assembled the most credited team of experts ... them all together on one website to offer the most on-trend, ... no cost and no calories to the consumer. , ...
... first 3 months more likely to have respiratory woes , , ... folic acid (folate) during early pregnancy may have an increased ... Folate is recommended to reduce the risk of birth defects, ... The researchers examined data on more than 32,000 children born ...
... behavior and screening have contributed greatly to the 13 percent ... playing a supporting role, according to new research from David ... first to report a long-term decline in cancer mortality, Cutler,s ... decline. Published in the fall edition of the Journal ...
... News/ -- EIN News has announced the launch of a new ... , With new advances in medicine, more and ... key components to surviving cancer. , ... about prostate cancer, its risk factors, screening procedures and drugs to ...
... Southern Research Institute -- a not-for-profit scientific organization that conducts ... discovery and development, advanced engineering, environmental and energy production -- ... Black & Veatch to help support the U.S. Department of ... , The award is expected ...
Cached Medicine News:Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:SkinnyAndTheCity.com Top Experts Create the Ultimate Lifestyle Guide 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Drop in cancer deaths tied primarily to gains in behavior and screening 2Health News:EIN News Introduces 'Prostate Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:Southern Research Wins $37 Million Black & Veatch Sub-Contract for Biological Threat Reduction Program 2Health News:Southern Research Wins $37 Million Black & Veatch Sub-Contract for Biological Threat Reduction Program 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: